Role of Recombinant Interferon-gamma Maintenance in Responding Patients with Small Cell Lung Cancer. A Randomised Phase III Study of the EORTC Lung Cancer Cooperative Group

Author： European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group   van Zandwijk N.   Groen H.J.M.   Postmus P.E.   Burghouts J.T.W.   ten Velde G.P.M.   Ardizzoni A.   Smith I.E.   Baas P.   Sahmoud T.   Kirkpatrick A.   Dalesio O.   Giaccone G.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.11, 1997-10, pp. : 1759-1766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases - a phase II study of the EORTC Lung Cancer Group (08965)

By Dziadziuszko R.   Ardizzoni A.   Postmus P.E.   Smit E.F.   Price A.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1271-1276

Elsevier

Access to resources Recommend Favorite

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

By Casal Rubio J.   Fírvida-Pérez J.   Lázaro-Quintela M.   Barón-Duarte F.   Alonso-Jáudenes G.   Santomé L.   Afonso-Afonso F.   Amenedo M.   Huidobro G.   Campos-Balea B.   López-Vázquez M.   Vázquez S.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 451-457

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite

Standard Versus Alternating Non-cross-resistant Chemotherapy in Extensive Small Cell Lung Cancer: An EORTC Phase III Trial

By Postmus P.E.   Scagliotti G.   Groen H.J.M.   Gozzelino F.   Burghouts J.T.W.   Curran D.   Sahmoud T.   Kirkpatrick A.   Giaccone G.   Splinter T.A.W.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1498-1503

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite